Skip to main content
TipRanks
Go Ultimate75% OFF

Restart Life Sciences (HEAL) Financial Statements

10 Followers

Restart Life Sciences Financial Overview

Restart Life Sciences's market cap is currently C$4.06M. The company's EPS TTM is C$-0.03; its P/E ratio is -1.59; Restart Life Sciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00C$ 25.41KC$ -3.79KC$ -5.00K
Operating IncomeC$ -1.35MC$ -658.51KC$ -1.23MC$ -1.94MC$ -2.93M
EBITDAC$ -1.34MC$ -656.20KC$ -1.20MC$ -1.84MC$ -2.68M
Net IncomeC$ -1.39MC$ 224.75KC$ -1.22MC$ -3.76MC$ -2.68M
Balance Sheet
Cash & Short-Term InvestmentsC$ 1.65MC$ 169.95KC$ 8.09KC$ 266.52KC$ 218.73K
Total AssetsC$ 1.77MC$ 190.40KC$ 31.06KC$ 296.79KC$ 881.16K
Total DebtC$ 245.36KC$ 79.88KC$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -1.35MC$ 68.56KC$ -8.09KC$ -266.52KC$ -218.73K
Total LiabilitiesC$ 480.21KC$ 489.47KC$ 841.66KC$ 255.44KC$ 422.06K
Stockholders' EquityC$ 1.29MC$ -299.07KC$ -810.60KC$ 41.34KC$ 459.10K
Cash Flow
Free Cash FlowC$ -717.22KC$ -71.77KC$ -277.53KC$ -1.44MC$ -1.95M
Operating Cash FlowC$ -717.22KC$ -71.77KC$ -277.53KC$ -1.44MC$ -1.95M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 29.64K
Financing Cash FlowC$ 2.30MC$ 75.00KC$ 19.10KC$ 1.49MC$ 0.00

Currency in CAD

Restart Life Sciences Earnings and Revenue History

-30M-15M015M-240000 %-160000 %-80000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Restart Life Sciences Liabilities to Assets

03M6M9M0 %1000 %2000 %3000 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Restart Life Sciences Cash Flow

-3M-2M-1M01M2M3M4M201720182019202020212022202320242025OperatingInvestingFinancing

Restart Life Sciences Forecast EPS vs Actual EPS

00000000Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss